Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-009439
Filing Date
2009-02-17
Accepted
2009-02-17 19:01:39
Documents
2
Period of Report
2009-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd233522.html 4  
1 FORM 4 rrd233522.xml 4 3719
2 POWER OF ATTORNEY rrd209330_236478.htm EX-24. 2704
  Complete submission text file 0001181431-09-009439.txt   8284
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 126 ISABELLA AVE ATHERTON CA 94027
Business Address
WALKER JOHN PETER (Reporting) CIK: 0001213529 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 09616650